FOR IMMEDIATE RELEASE MIAMI, FL — Cellular Hope Institute, the clinical division of Global Stem Cells Group and Regenerative Medical Technology Group, Inc. (OTC Markets: RMTG), today announced an expanded international patient strategy targeting individuals traveling from the United States and Canada to its Cancun facilities. The institute is developing comprehensive, premium medical-wellness programs combining

FOR IMMEDIATE RELEASE MIAMI, FL — Cellular Hope Institute, the clinical division of Global Stem Cells Group and Regenerative Medical Technology Group, Inc. (OTC Markets: RMTG), today announced a significant expansion of its clinical facilities in Cancun, Mexico, introducing additional physician-directed longevity, wellness, and complementary technology capabilities. The expansion adds hyperbaric medicine, red-light/photobiomodulation therapies, PEMF,

FOR IMMEDIATE RELEASE MIAMI, FL — The International Society for Stem Cell Application (ISSCA), the physician-education division of Global Stem Cells Group and Regenerative Medical Technology Group, Inc. (OTC Markets: RMTG), today announced ISSCA 129, its return to Dubai, United Arab Emirates, December 4–5 at the Hyatt Regency Dubai Creek Heights, closing ISSCA’s international conference

FOR IMMEDIATE RELEASE MIAMI, FL — The International Society for Stem Cell Application (ISSCA), the physician-education division of Global Stem Cells Group and Regenerative Medical Technology Group, Inc. (OTC Markets: RMTG), today announced ISSCA 127, its second São Paulo, Brazil congress of 2026, taking place November 20–21 in the city’s Vila Olímpia district, following ISSCA’s

FOR IMMEDIATE RELEASE MIAMI, FL — The International Society for Stem Cell Application (ISSCA), the physician-education division of Global Stem Cells Group and Regenerative Medical Technology Group, Inc. (OTC Markets: RMTG), today announced ISSCA 128, its conference in Bogotá, Colombia, taking place November 27–28 at the Hilton Bogotá Corferias. The Bogotá conference continues ISSCA’s ongoing

FOR IMMEDIATE RELEASE MIAMI, FL — The International Society for Stem Cell Application (ISSCA), the physician-education division of Global Stem Cells Group and Regenerative Medical Technology Group, Inc. (OTC Markets: RMTG), today announced ISSCA 126, its regenerative medicine conference in Santa Cruz de la Sierra, Bolivia, taking place October 23–24 at Hotel Los Tajibos. The

FOR IMMEDIATE RELEASE MIAMI, FL — The International Society for Stem Cell Application (ISSCA), the physician-education division of Global Stem Cells Group and Regenerative Medical Technology Group, Inc. (OTC Markets: RMTG), today announced a new educational program focused on complementary and adjunctive technologies increasingly incorporated into longevity and regenerative medicine practices. Curriculum areas include therapeutic

FOR IMMEDIATE RELEASE MIAMI, FL — The International Society for Stem Cell Application (ISSCA), the physician-education division of Global Stem Cells Group and Regenerative Medical Technology Group, Inc. (OTC Markets: RMTG), today announced its 2026 Global Summit — ISSCA 125 — taking place September 25–27 at the JW Marriott Cancun Resort & Spa. The Summit

FOR IMMEDIATE RELEASE MIAMI, FL — The International Society for Stem Cell Application (ISSCA), the physician-education division of Global Stem Cells Group and Regenerative Medical Technology Group, Inc. (OTC Markets: RMTG), today announced Peptide Certification 2.0, a major expansion of its peptide medicine education and certification program. The updated program includes expanded curriculum modules, updated

FOR IMMEDIATE RELEASE MIAMI, FL — The International Society for Stem Cell Application (ISSCA), the physician-education division of Global Stem Cells Group and Regenerative Medical Technology Group, Inc. (OTC Markets: RMTG), today announced the next generation of its Online Academy, adding curriculum modules covering biologics, exosomes, mesenchymal stromal/stem cells (MSCs), Natural Killer cells, dendritic cells,

FOR IMMEDIATE RELEASE MIAMI, FL — The International Society for Stem Cell Application (ISSCA), the physician-education division of Global Stem Cells Group and Regenerative Medical Technology Group, Inc. (OTC Markets: RMTG), today announced the launch of a comprehensive new fellowship designed for physicians and point-of-care regenerative medicine providers. The curriculum integrates regenerative medicine modalities, emerging

FOR IMMEDIATE RELEASE MIAMI, FL — Cellgenic, the biotechnology and product-commercialization division of Global Stem Cells Group and Regenerative Medical Technology Group, Inc. (OTC Markets: RMTG), today announced its sponsorship of Congreso Internacional Medéstetica 2026 in Buenos Aires, Argentina. Congreso Medéstetica 2026 runs August 19–21 at Salguero Plaza in Buenos Aires and combines four concurrent